Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02732678
What this trial is testing

Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)

Who this might be right for
Angiosarcoma
Assistance Publique Hopitaux De Marseille 24
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06524778
What this trial is testing

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Who this might be right for
Osteosarcoma
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00061659
What this trial is testing

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Abbott 88
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Post-approval studies (Phase 4)UnknownNCT00339118
What this trial is testing

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Who this might be right for
Rhabdomyosarcoma
Sheba Medical Center
Not applicableLooking for participantsNCT06805669
What this trial is testing

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

Who this might be right for
Sarcoma
Mount Sinai Hospital, Canada 136
Early research (Phase 1)Study completedNCT03283696
What this trial is testing

Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 24
Not applicableLooking for participantsNCT05653388
What this trial is testing

Metastatic Leiomyosarcoma Biomarker Protocol

Who this might be right for
Leiomyosarcoma
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00005066
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University of Chicago 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Looking for participantsNCT07291297
What this trial is testing

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma MetastaticSarcoma, Soft Tissue
Wake Forest University Health Sciences 50
Testing effectiveness (Phase 2)Looking for participantsNCT06578624
What this trial is testing

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Lamassu Bio Inc 70
Large-scale testing (Phase 3)Study completedNCT00354744
What this trial is testing

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Who this might be right for
Sarcoma
Children's Oncology Group 109
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Not applicableStudy completedNCT04690231
What this trial is testing

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, DrugSecondary Resistance
Peking University People's Hospital 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551430
What this trial is testing

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic Soft-tissue Sarcoma
Washington University School of Medicine 105
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Early research (Phase 1)Ended earlyNCT05130255
What this trial is testing

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Who this might be right for
SCLCMalignant MelanomaSarcoma+1 more
Y-mAbs Therapeutics 23
Next Page